Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME T2D trial
2006-002519-28Phase 4Active
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Premixed insulin lispro arm with Insulin glargine plus lispro arm (2 arms). Primary endpoints: HbA1c at end of study, HbA1c at 12 weeks and 1 more. Started Jul 2006; status: active.
02
Drugs
insulin lispro + insulin lispro protamineinsulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002519-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002519-28.